Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Addex Therapeutics (ADXN) Return on Assets: 2022-2025

Historic Return on Assets for Addex Therapeutics (ADXN) over the last 2 years, with Jun 2025 value amounting to -0.45%.

  • Addex Therapeutics' Return on Assets changed negligibly% to -0.45% in Q2 2025 from the same period last year, while for Jun 2025 it was -0.45%, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of 1.57% for FY2024, which is 287.00% up from last year.
  • Addex Therapeutics' Return on Assets amounted to -0.45% in Q2 2025, which was up 5.39% from -0.47% recorded in Q1 2025.
  • Over the past 5 years, Addex Therapeutics' Return on Assets peaked at 0.28% during Q3 2023, and registered a low of -1.24% during Q1 2024.
  • For the 3-year period, Addex Therapeutics' Return on Assets averaged around -0.48%, with its median value being -0.45% (2024).
  • Its Return on Assets has fluctuated over the past 5 years, first slumped by 64bps in 2024, then skyrocketed by 77bps in 2025.
  • Addex Therapeutics' Return on Assets (Quarterly) stood at -1.08% in 2022, then grew by 23bps to -0.85% in 2023, then spiked by 43bps to -0.42% in 2024, then remained steady at -0.45% in 2025.
  • Its Return on Assets was -0.45% in Q2 2025, compared to -0.47% in Q1 2025 and -0.42% in Q4 2024.